Skip to main content
Caplight Logo









Lake Bleu Capital

Lake Bleu Capital

Hong Kong, Hong Konglakebleu-cap.com

Overview

Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare in Asia/Greater China . With a long-term investment horizon, it manages strategies through both public and private equity investments, focusing primarily on mid-to-late-stage investments . The firm specializes in investing in the healthcare, pharmaceutical, and technology innovation sectors .

Year Founded

2018

Portfolio Companies

31

Investments

Lake Bleu Capital investments
CompanyDateStageLead
Beijing Safe Pharmaceutical Technology Co., Ltd.Feb 2021IPOCo-investor
New Ruipeng Pet Healthcare GroupSep 2020StrategicCo-investor
New Ruipeng Pet Healthcare GroupSep 2020StrategicCo-investor
Brii BiosciencesMar 2021Series CCo-investor
RemeGenNov 2020IPOCo-investor
Book a demo to see all 31 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Lake Bleu Capital based?

Lake Bleu Capital is headquartered in Hong Kong, Hong Kong, Hong Kong.

When was Lake Bleu Capital founded?

Lake Bleu Capital was founded in 2018.

How many portfolio companies does Lake Bleu Capital have?

Lake Bleu Capital has 31 portfolio companies in Caplight's dataset.

What are some companies in Lake Bleu Capital's portfolio?

Portfolio companies visible on Caplight include Beijing Safe Pharmaceutical Technology Co., Ltd., New Ruipeng Pet Healthcare Group, New Ruipeng Pet Healthcare Group, Brii Biosciences, RemeGen.

What was Lake Bleu Capital's most recent investment shown here?

Lake Bleu Capital's most recent investment in this portfolio sample was in Brii Biosciences in 2021.

What sectors does Lake Bleu Capital focus on?

Lake Bleu Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, FinTech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.

What company stages does Lake Bleu Capital focus on?

Lake Bleu Capital typically invests at the Early stage.

What is Lake Bleu Capital's AUM?

Lake Bleu Capital's assets under management are estimated between $1.0B and $10.0B.

Firmographic Details

HeadquartersHong Kong, Hong Kong
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?